Ocean Biomedical CEO Elizabeth Ng (L) and Aesther CEO Suren Ajjarapu

Af­ter ditch­ing elec­tric ve­hi­cle parts mak­er, a SPAC choos­es a Brown spin­out that had test­ed the IPO wa­ters

While the mar­ket re­mains dif­fi­cult to nav­i­gate, the lat­est SPAC merg­er shows that biotechs and blank checks are still will­ing to brace the chop­py wa­ters …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.